Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 10/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | GSK3A | P49840 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ICMT | O60725 | 1/20 | 0.37 |
| ▸ | PTGES | O14684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL541529 | 1.00 | CASR (0.43) | CASRSMN1; SMN2GSK3AGSK3BPPARG | |
| SCHEMBL541461 | 0.91 | CASR (0.47) | CASRSMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL541235 | 0.91 | CASR (0.47) | CASRSMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL542073 | 0.88 | CASR (0.49) | CASRSMN1; SMN2PPARG | |
| SCHEMBL3946612 | 0.88 | CASR (0.49) | CASRSMN1; SMN2PPARG | |
| SCHEMBL541466 | 0.88 | CASR (0.42) | CASRSMN1; SMN2PPARGKMT2AMEN1 | |
| SCHEMBL541231 | 0.88 | CASR (0.42) | CASRSMN1; SMN2PPARGKMT2AMEN1 | |
| SCHEMBL541302 | 0.87 | CASR (0.40) | CASRGSK3AGSK3BPPARGICMT | |
| SCHEMBL541702 | 0.87 | CASR (0.40) | CASRGSK3AGSK3BPPARGICMT | |
| SCHEMBL541318 | 0.86 | CASR (0.53) | CASRSMN1; SMN2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1509518-B1 | CALCIUM RECEPTOR MODULATING AGENTS | AMGEN INC (US) | 2012-02-08 | — | — | EP | claimed |